268 related articles for article (PubMed ID: 20218749)
1. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
Perry CM
Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
[TBL] [Abstract][Full Text] [Related]
2. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
Stein EA; Marais AD; Szamosi T; Raal FJ; Schurr D; Urbina EM; Hopkins PN; Karki S; Xu J; Misir S; Melino M
J Pediatr; 2010 Feb; 156(2):231-6.e1-3. PubMed ID: 19879596
[TBL] [Abstract][Full Text] [Related]
3. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Davidson M
Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
[TBL] [Abstract][Full Text] [Related]
5. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
[TBL] [Abstract][Full Text] [Related]
6. Colesevelam: a review of its use in hypercholesterolemia.
Robinson DM; Keating GM
Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
[TBL] [Abstract][Full Text] [Related]
7. Colesevelam hydrochloride: a novel bile acid-binding resin.
Aldridge MA; Ito MK
Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
[TBL] [Abstract][Full Text] [Related]
8. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
9. Colesevelam: a new and improved bile acid sequestrant?
Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
[TBL] [Abstract][Full Text] [Related]
11. Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.
Florentin M; Liberopoulos EN; Mikhailidis DP; Elisaf MS
Curr Med Res Opin; 2008 Apr; 24(4):995-1009. PubMed ID: 18291066
[TBL] [Abstract][Full Text] [Related]
12. Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.
Davidson MH; Dicklin MR; Maki KC; Kleinpell RM
Expert Opin Investig Drugs; 2000 Nov; 9(11):2663-71. PubMed ID: 11060828
[TBL] [Abstract][Full Text] [Related]
13. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
[TBL] [Abstract][Full Text] [Related]
14. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
Davidson MH; Dillon MA; Gordon B; Jones P; Samuels J; Weiss S; Isaacsohn J; Toth P; Burke SK
Arch Intern Med; 1999 Sep; 159(16):1893-900. PubMed ID: 10493319
[TBL] [Abstract][Full Text] [Related]
15. Colesevelam.
Melian EB; Plosker GL
Am J Cardiovasc Drugs; 2001; 1(2):141-6; discussion 147-8. PubMed ID: 14728043
[TBL] [Abstract][Full Text] [Related]
16. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
[TBL] [Abstract][Full Text] [Related]
17. Role of colesevelam in combination lipid-lowering therapy.
Jones MR; Nwose OM
Am J Cardiovasc Drugs; 2013 Oct; 13(5):315-23. PubMed ID: 23913404
[TBL] [Abstract][Full Text] [Related]
18. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
Brunetti L; Hermes-Desantis ER
Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
Insull W; Toth P; Mullican W; Hunninghake D; Burke S; Donovan JM; Davidson MH
Mayo Clin Proc; 2001 Oct; 76(10):971-82. PubMed ID: 11605698
[TBL] [Abstract][Full Text] [Related]
20. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
Corsini A; Windler E; Farnier M
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
